Navigation Links
New Study First to Confirm Sandostatin LAR(R) Depot Controls Tumor Growth in Patients With Rare Gastrointestinal Tumors
Date:1/13/2009

- Data show significant 66% reduction in risk of disease progression versus placebo

- Sandostatin LAR more than doubled time without tumor growth for a median of 14 months compared to six months on placebo

- Results support Sandostatin LAR as first treatment after surgery in certain patients with newly diagnosed neuroendocrine tumors (NETs)

EAST HANOVER, N.J., Jan. 13 /PRNewswire/ -- Sandostatin LAR(R) Depot (octreotide acetate suspension for injection) demonstrated antitumor benefit in patients with metastatic neuroendocrine tumors (NETs) of the midgut, according to interim data presented today at the 2009 Gastrointestinal Cancer Symposium of the American Society of Clinical Oncology.

After six months of treatment, patients receiving Sandostatin LAR had a 66% reduction in risk of disease progression compared to patients taking placebo (P=0.000072). This reduction is based on findings that Sandostatin LAR halted tumor growth in 69% of patients, compared with 39% of patients receiving placebo. Patients who took Sandostatin LAR had no tumor progression for a median of 14.3 months, compared to six months for patients on placebo. This beneficial effect was seen in patients with either functioning (hormone secreting) or non-functioning (non-secreting) NETs.

The findings are from a Phase IIIb, multicenter, prospective, randomized, placebo-controlled, double-blind, study called PROMID (Placebo-controlled prospective Randomized study on the antiproliferative efficacy of Octreotide LAR in patients with metastatic neuroendocrine MIDgut tumors).

"Sandostatin LAR has a proven track record of treating the severe diarrhea and flushing associated with neuroendocrine tumors and now this study demonstrates that Sandostatin LAR also helps control tumor growth in patients with metastatic neuroendocrine tumors of the midgut," said PROMID
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. VA-NIH Study Offers Hope for Parkinsons Patients
2. Uroplasty Highlights Results From Clinical Study on Macroplastique(R) for the Treatment of Stress Urinary Incontinence
3. Reproductive Partners Participates in New IVF Progesterone Delivery System Study
4. Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
5. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
6. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
7. ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers
8. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
9. Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer
10. Major deCODE-led Study Underscores Role of the Brain in Obesity
11. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... FRANKLIN, Ohio , Jan. 15, 2014  A novel wearable ... it easy and painless for patients to self-inject prescription drugs ... of disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic ... expected to grow to $220B by 2018, according to analysts.   ...
(Date:1/14/2014)... 2014  Luminex Corporation (Nasdaq: LMNX ) today announced ... of 2013 on Monday, February 3, 2014. A press release ... of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... operating highlights and financial results for the fourth quarter and ...
(Date:1/14/2014)... , Jan. 14, 2014 The Brandeis Medical Center, led ... a premier and affordable laser tattoo removal experience with ... Brandeis, focus is in providing high quality cosmetic services with cutting ... " Southern California has seen a ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... Fla., July 5, 2011 MSC Care Management, a ... management solutions to the workers, compensation industry, has launched ... to help relieve the administrative burden for claims adjusters ... a proprietary online tool that allows for faster and ...
... Tourette Syndrome Association, Inc., (TSA) has unveiled a 115-square ... generate awareness and acceptance of all people living with ... "We Have Tourette,s But Tourette,s Doesn,t Have Us" is ... everyday with the symptoms of involuntary sounds and movements ...
Cached Medicine Technology:MSC CareConnect Provides Real-Time, Online Communication and Referral Management to Claims Professionals 2EHE International Showcases The National Tourette Syndrome Association, Inc. with Month-Long Window Display in Rockefeller Center Plaza 2
(Date:4/23/2014)... predict which patients might suffer potentially fatal side-effects from ... assesses brain scans using pattern recognition software similar to ... been developed by researchers at Imperial College London. Results ... which used the software are published in the journal ... 15 million people each year worldwide. Ischemic strokes are ...
(Date:4/23/2014)... benefits of probiotics, antioxidants and other nutritional compounds, more ... industry is getting in on the action. But legitimate ... the industry is responding with clinical research to shore ... Chemical & Engineering News (C&EN), the weekly ... M. Bomgardner, a senior editor at C&EN, writes that ...
(Date:4/23/2014)... SEATTLE, Washington, April 21, 2014 Five for-profit ... total of $1.25 million in Proof of Concept ... from ideas into commercial products, the Life Sciences ... a $300,000 Entrepreneur Mentoring Program grant to the ... a statewide advisory network to train the next ...
(Date:4/23/2014)... Effects of Midlife Occupational and Leisure Time Physical Activity ... physical activity in midlife increases the risk of mobility ... the risk. This is found in a study which ... The study was conducted at the Gerontology Research Center ... , Heavy physical labor is often repetitive, wears the ...
(Date:4/23/2014)... shown that proliferation of endogenous neural precursor cells ... and axons. From the perspective of neural plasticity, ... University in China observed the effects of functional ... proliferation and expression of basic fibroblast growth factor ... on the infarct side. The researchers found that ...
Breaking Medicine News(10 mins):Health News:Airport security-style technology could help doctors decide on stroke treatment 2Health News:Airport security-style technology could help doctors decide on stroke treatment 3Health News:LSDF announces commercialization grants and Entrepreneur Mentoring Program 2Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2
... of bird flu which had reached a feverish pitch early in ... //if the virus has actually beaten a retreat. , ... flu is dynamic in the winter months, as the virus can ... The H5N1 virus which had earlier restricted itself to Southeast Asia ...
... the University of North Carolina at Chapel Hill School of ... according to a study by an international group of researchers. ... by Dr. Carol Otey and her former student, Dr. Mana ... in Boston. Otey has shown that palladin is involved in ...
... basic symptoms associated with ovarian cancer may aid clinicians ... a new study.// This index is expected to serve ... details of this study is published in the January ... of the American Cancer Society, the study reveals that ...
... thousands of quails at a farm in Kimje.// It was ... a farm in Kimje, 262 kilometers southwest of Seoul to the ... in the farm of the latest outbreak. ,This recent ... starting with an first outbreak of highly virulent H5N1 virus on ...
... (Australia) government has decided //to toughen its laws on anti-smoking. ... carrying children. This comes in the wake of ... dies every 18 days, when exposed to cigarette smoke. ... Queenslanders Report, 2006, made these comments. ,A review ...
... University School of Medicine have found out that successful lung ... in many smokers. This study published in the December issue ... look at smoking relapse among people who were "forced" to ... found that close to half of 154 smokers who had ...
Cached Medicine News:Health News:Gene Discovered by Researchers Tied to Pancreatic Cancer 2Health News:A Basic Symptom Index For Early Detection Of Ovarian Cancer 2Health News:Lung Cancer Surgeries Doesn’t Help Breaking Nicotine Dependence in Smoker 2Health News:Lung Cancer Surgeries Doesn’t Help Breaking Nicotine Dependence in Smoker 3
... components that comprise the SmartPill GI ... comprise the SmartPill GI Monitoring System: ... Receiver software and SmartPill MotiliGI software. ... indispensable parts of the SmartPill GI ...
... for POLYGRAM NET™ (PNET) works with ... record and analyze pressure, swallow, and ... procedures. The PNET software and Polygraf ... water-perfused manometry catheters and the RespSponse™ ...
... Advanced pH Analysis for POLYGRAM NET™ ... Testing Application. Like the standard application, Advanced ... by either the Digitrapper™ Catheter-Based pH Recorder ... ,Designed primarily for use by clinical ...
Capillaries available in glass and "non-PVC" plastic. Match different analyzer requirements. Variety of sizes match sample-volume requirements of individual analyzers....
Medicine Products: